Publications
More than 100 publications and research posters based on Carenity studies
Dramatic improvement in treatment acceptance observed in patients with Multiple Sclerosis switching treatment: a real-world study
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018 Collaborator: ...
MS patients’ perception of the effects of PR-fampridine on walking disorders and daily life: results from an observational study conducted via an online community
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018 Collaborator: ...
Walking disorders in MS: how do they impact patients’ quality of life? Results from an observational study conducted via an online patient community
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018 Collaborator: ...
What are the most valued patient outcomes regarding medical care for French patients with type 1 diabetes? Results from an online patient community
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR EU) 2018 ...
How can Acceptance Measurement Help Understanding Patients’ Concerns and Working on Solutions? (Crohn’s Disease, COPD, Osteoarthritis)
Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR US) 2018 Collaborator: ...
Multiple sclerosis clinical trials: how to encourage patient participation?
Presented at European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2018 ...
How do Transplanted Patients manage their risk of Non Melanoma Skin Cancer?
Presented at European Association of Dermato Oncology (EADO) 2018 Collaborator: Pierre Fabre ...
Patients’ behavior and risk perception of non-melanoma skin cancer after organ transplant: what are patients’ expectations for new preventive treatments?
Presented at European Association of Dermato Oncology (EADO) 2018 Collaborator: Pierre Fabre ...
Vécu des patients sous biothérapies et biosimilaires dans la maladie de Crohn
Vécu des patients sous biothérapies et biosimilaires dans la maladie de Crohn - ...